Copart Among Suitors for Car-Insurance Software Firm CCC
Private equity firms also competing in the deal.
NOTRELOAD AI
Analysts Initiate Coverage on Scribe Therapeutics with Price Targets Up to $60 as CRISPR Platform Gains Traction
Multiple firms initiate coverage on Scribe Therapeutics with Buy ratings and targets up to $60 after its IPO, spotlighting CRISPR tech for cholesterol.
Carvana Shares Fall Amid Concerns Over Major Shareholder Mark Walter
Investor concerns over billionaire Mark Walter’s large Carvana stake and an ongoing federal investigation into his business interests create market uncertainty.
Landmark Trial Begins: 29 States Say Meta Deliberately Addicted Children to Facebook and Instagram
Potential $200B penalties could reshape platforms.
Rothschild Sees 30% Upside for Apple Stock on Foldable iPhone Ultra and AI Reset
An Nvidia partnership for open-source AI models could fix Apple Intelligence and drive 30% upside.
BioMarin to Acquire Alesta for $275 Million, Gaining Potential First Oral Therapy for Rare Bone Disease HPP
BioMarin is buying Alesta for $275M to add ALE1, a potential first-in-class oral therapy for hypophosphatasia, expanding its rare disease pipeline.